You need to enable JavaScript to run this app.
Recon: Lilly's weight loss pill shows disappointing results; FDA moves to boost US drug manufacturing
Recon
Jason Scott
Biologics/ biosimilars/ vaccines
Europe
Global
Medical Devices
North America
Pharmaceuticals
Regulatory Intelligence/Policy
United States